Print Version
Medication Tracker: The 4 Months Daily Rifampin Schedule for Latent Tuberculosis (TB) Infection
Author:
Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination
Publication Date:
2020
Country of Origin:
United States
Format:
Brochure
Language:
English
How to Access this Material:
HTML: https://www.cdc.gov/tb/topic/treatment/ltbi.htm
PDF: https://www.cdc.gov/tb/education/pdf/4R-MedicationTracker-508.pdf
HTML: https://www.cdc.gov/tb/topic/treatment/ltbi.htm
PDF: https://www.cdc.gov/tb/education/pdf/4R-MedicationTracker-508.pdf
Abstract
This material was developed for clinicians to use with patients that are prescribed the four months daily rifampin (4R) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 4R regimen.
Publisher:
CDC NCHHSTP Division of Tuberculosis Elimination
Audience(s):
Health Professionals, Persons With LTBI, Physicians
Topic:
Diagnosis, TB Treatment, Treatment - Latent TB infection (Inactive TB), Treatment- Medication Information, Treatment- Patient Adherence
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.